JP
Revvity Sites Globally
Select your location.
*e-commerce not available for this region.
AlphaPlate 384-well, light gray, untreated, case of 50
AlphaPlate 384-well, light gray, untreated, case of 50
AlphaPlate-384, Light gray, untreated image
| Feature | Specification |
|---|---|
| Surface Treatment | Untreated |
| Color | Gray |
| Detection Modality |
Alpha Luminescence |
| Lids Included? | No |
| Material | Polystyrene |
| Sterility | Non-Sterile |
| Plate Format | 384 wells |
| Well Shape | Flat-bottom |
| Well Volume | 105 µL |
| Working Volume | 24 - 90 µL |
For research use only. Not for use in diagnostic procedures.
AlphaPlate 384-well, light gray, untreated, case of 50
AlphaPlate-384, Light gray, untreated image
AlphaPlate 384-well, light gray, untreated, case of 50
Product information
Overview
Packaging notes:
- Cases of 50 are packaged as 2 sleeves of 25 plates each. Each sleeve as 5 wraps with 5 plates.
- Cases of 200 are packaged as 8 sleeves of 25 plates each. Each sleeve as 5 wraps with 5 plates.
Well plate dimensions
Well format: 384-well
| Description | Specification |
|---|---|
| Number of rows | 16 |
| Number of columns | 24 |
| Well volume | 105 µL |
| Recommended working volume | 24 µL- 90 µL |
| Height (mm) | 14.35 |
| Length (mm) | 127.76 |
| Width (mm) | 85.48 |
| Well diameter (mm) | 3.65 |
| Well depth (mm) | 10.4 |
| A1 to top offset (mm) | 9.0 |
| A1 to side offset (mm) | 12.10 |
| Well-to-well spacing (mm) | 4.50 |
| Volume | 105 μL |
Specifications
| Color |
Gray
|
|---|---|
| Plate Format |
384 wells
|
| Well Shape |
Flat-bottom
|
| Well Volume |
105 µL
|
| Working Volume |
24 - 90 µL
|
| Application |
Research
|
|---|---|
| Automation Compatible |
Yes
|
| Brand |
AlphaPlate
|
| Detection Modality |
Alpha
Luminescence
|
| Format |
Microplates
|
| Lids Included? |
No
|
| Material |
Polystyrene
|
| Shipping Conditions |
Shipped Ambient
|
| Sterility |
Non-Sterile
|
| Surface Treatment |
Untreated
|
| Unit Size |
case of 50
|
Resources
Are you looking for resources, click on the resource type to explore further.
Application Note
Detection of MAPK activation to evaluate the efficacy and potency of KRAS/SOS1 inhibitors by AlphaLISA and HTRF technologies
Evaluation of the therapeutic profile of anti-oncogene compounds in various cell lines with AlphaLISA™ and HTRF™
KRAS is a proto...
Application Note
Determination of cytokines present in a CAR-T co-culture environment by AlphaLISA and HTRF technologies
Explore how advanced immunoassay platforms can enhance your CAR-T research:
- Dual-technology approach: Compare AlphaLISA and HTRF...
Application Note
Measuring strong to weak binding interactions with AlphaLISA
Biomolecular interactions are crucial for biological processes like transcription, translation, and cell signaling. These...
Application Note
No-Wash IP1 assays are a powerful readout to characterize compounds modulating the FGFR signaling pathway in cancer drug research
The success of cancer therapies can be influenced by the interaction between multiple signaling pathways. Dysregulated FGFR...
Application Note
Simultaneous detection of drug efficacy and toxicity by combining HTRF, AlphaLISA, or AlphaLISA SureFire Ultra with ATPlite
This application note demonstrates how compound’s mechanism of action and potential cytotoxic effects can be deciphered thanks to...
Application Note
Simultaneous measurement of chemokine/cytokine release and antibody-dependent cellular cytotoxicity upon binding with rituximab
Antibody-dependent cellular cytotoxicity (ADCC) is a cell-mediated immune response where an effector cell destroys an antibody...
How can we help you?
We are here to answer your questions.
